Does prednisone cause neutrophilia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Prednisone Cause Neutrophilia?

Yes, prednisone definitively causes neutrophilia—this is a well-established pharmacologic effect documented in both FDA labeling and extensive clinical research.

Mechanism and Clinical Evidence

Prednisone and other corticosteroids consistently induce neutrophilia through multiple mechanisms. The FDA drug label for prednisone explicitly lists neutropenia (including febrile neutropenia) under hematologic adverse reactions, but the predominant hematologic effect is actually neutrophilic leukocytosis 1.

Key Mechanisms:

  • Demargination: Corticosteroids impair neutrophil adhesion to vascular endothelium by down-regulating L-selectin and Mac-1 expression by 35-40%, causing marginated neutrophils to return to circulation 2
  • Reduced tissue migration: Decreased egress of neutrophils from blood vessels into tissues, with corresponding reduction in neutrophil turnover rate 3
  • G-CSF induction: Methylprednisolone increases granulocyte-colony stimulating factor levels 2-3 fold, potentially enhancing neutrophil production and release 2

Magnitude and Timing of Effect

The neutrophilia follows a predictable pattern:

  • Peak effect: 4-6 hours after administration 4
  • Magnitude: Dose-dependent increase
    • Low-dose steroids: mean increase of 0.3 × 10⁹/L
    • Medium-dose: 1.7 × 10⁹/L
    • High-dose: up to 4.84 × 10⁹/L within 48 hours 5
  • Duration: A second rise may occur at 24 hours after oral dosing 4

After a single 2 mg/kg dose of prednisone, neutrophil counts rise to 1.5-3.6 times baseline values 3.

Clinical Implications and Pitfalls

Critical Diagnostic Considerations:

When evaluating leukocytosis in patients on corticosteroids, increases up to 4.84 × 10⁹/L within 48 hours of high-dose steroids are expected and do not necessarily indicate infection 5. Larger increases, or any significant increase after low-dose steroids, should prompt investigation for alternative causes including infection.

Associated Hematologic Changes:

Corticosteroids cause a characteristic pattern beyond neutrophilia:

  • Lymphocytopenia (particularly T-cells) 6, 4
  • Eosinopenia 6
  • Monocytopenia 6
  • The neutrophilia consists predominantly of mature neutrophils 4

Important Caveat - Bandemia:

While mature neutrophilia is expected, recent evidence suggests high-dose dexamethasone may also cause bandemia (immature neutrophils) in otherwise healthy patients without infection 7. This is a newer observation that clinicians should recognize to avoid misinterpreting band forms as evidence of bacterial infection.

Functional Considerations:

Despite the increased neutrophil count, neutrophil bactericidal capacity and lysozyme activity are actually depressed during prednisone treatment 8. The neutrophilia represents a quantitative increase but not necessarily enhanced antimicrobial function—in fact, corticosteroids increase infection risk through immunosuppression 1.

Clinical Context from Guidelines

Multiple ASCO guidelines managing immune-related adverse events consistently use prednisone 0.5-2 mg/kg/day for various hematologic conditions 9, 10. These guidelines acknowledge that corticosteroids are lymphocyte-depleting therapy and include steroids in the differential diagnosis when evaluating cytopenias 10.

The neutrophilia is a predictable, dose-dependent pharmacologic effect that resolves after steroid discontinuation, with all parameters typically returning to baseline within 48 hours of completing a therapeutic course 2.

Related Questions

Does prednisone affect the absolute neutrophil count (ANC), and how should a low ANC be evaluated and managed in a patient taking prednisone?
In a patient receiving systemic steroids (e.g., prednisone ≥10–20 mg/day), how can I differentiate whether leukocytosis is due to infection or steroid effect?
What to do with an adult patient with leukocytosis (elevated white blood cell count) to 17,000 with neutrophilic predominance while on steroid (corticosteroid) therapy?
In an 82-year-old woman with a white blood cell count increasing from 11.6 ×10⁹/L to 13.1 ×10⁹/L and neutrophil proportion rising from 61% to 71% over 24 hours, what is the likely cause and recommended management?
In a patient who received a single 50 mg dose of prednisone and recently underwent chemotherapy, with a leukocyte count of 11.5 ×10⁹/L, elevated C‑reactive protein, and low‑grade fever (37.5‑37.7 °C), is the leukocytosis likely a prednisone side effect or indicative of an underlying inflammatory or infectious process?
Is it common to develop a small area of soft‑tissue swelling on the chest after a left‑heart catheterization?
What are the possible causes of a low white blood cell count?
How should calcipotriene be used to treat plaque psoriasis, including dosing, contraindications, and monitoring?
What is the appropriate management for non‑Helicobacter pylori duodenitis?
What is the recommended management of a patient with rheumatoid arthritis who develops a cytokine storm?
In a self‑pay patient with lumbar facet joint arthropathy, what is the optimal medication regimen and procedural intervention to manage his pain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.